Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of KLARIA PHARMA HOLDING AB
No Price
Closing Price XSTO 29.04.2026:
0,90 SEK
29.04.2026 09:30
Current Prices from KLARIA PHARMA HOLDING AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
KLAR.ST
SEK
29.04.2026 09:30
0,90 SEK
-0,02 SEK
-1,64 %
Share Float & Liquidity
Free Float39,03 %
Shares Float133,48 M
Shares Outstanding342 M
Company Profile for KLARIA PHARMA HOLDING AB Share
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.
